Haloperidol Clinical Trials

• Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression
  ClinicalTrials.gov Identifier: NCT00340379 - Active, not recruiting
  Affective Disorders
  
• Post-Operative Haloperidol Versus Placebo for Prevention of Post-Operative Delirium After Acute Hip Surgery.
  ClinicalTrials.gov Identifier: NCT00250237 - Recruiting
  Post-Operative Delirium; Hip Fracture
  
• A Comparison of Study Drug with Placebo and Haloperidol in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00044044 - Active, not recruiting
  Schizophrenia
  
• A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room
  ClinicalTrials.gov Identifier: NCT00457366 - Recruiting
  Agitation
  
• Maintenance Treatment Vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00159120 - Active, not recruiting
  Schizophrenia; Psychoses
  
• Prodrome-Based Early Intervention with Antipsychotics Vs. Benzodiazepines in First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00159133 - Active, not recruiting
  Schizophrenia; Psychoses
  
• One Year Drug Treatment in First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00159081 - Active, not recruiting
  Schizophrenia
  
• Optimization of Acute Treatment in First Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00157378 - Active, not recruiting
  Schizophrenia, first-episode
  
• A Comparison of Dexmedetomidine and Haloperidol in Patients With ICU-Associated Agitation and Delirium
  ClinicalTrials.gov Identifier: NCT00505804 - Recruiting
  Delirium; Agitation; Ventilator Weaning; Respiration, Artificial; Intensive Care
  
• Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00395915 - Recruiting
  Schizophrenia
  
• Study Comparing Olanzapine with Haloperidol for the Relief of Nausea and Vomitting in Patients with Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00124930 - Recruiting
  Refractory Nausea
  
• Pilot Study of Haloperidol to Treat Critical Illness Delirium
  ClinicalTrials.gov Identifier: NCT00429676 - Recruiting
  Delirium; Critical Illness
  
• Clozapine IM and Aggression in Schizophrenic Patients
  ClinicalTrials.gov Identifier: NCT00189995 - Not yet recruiting
  Schizophrenia
  
• To Determine If Olanzapine Is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00007774 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00018642 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone
  ClinicalTrials.gov Identifier: NCT00361166 - Completed
  Schizophrenia
  
• A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia
  ClinicalTrials.gov Identifier: NCT00249119 - Completed
  Psychotic Disorder; Schizophrenia
  
• A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia
  ClinicalTrials.gov Identifier: NCT00249132 - Completed
  Schizophrenia; Psychotic Disorders
  
• 5HT3 Antagonism and Auditory Gating in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00018850 - Completed
  Schizophrenia
  
• Open label trial exploring a switch from oral medications, to risperidone depot microspheres
  ClinicalTrials.gov Identifier: NCT00034775 - Completed
  Schizophrenia
  
• Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00485901 - Completed
  Schizophrenia
  
• Agitation in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00000179 - Completed
  Alzheimer Disease
  
• The MIND Study: Modifying the INcidence of Delirium
  ClinicalTrials.gov Identifier: NCT00096863 - Completed
  Delirium; Cognition Disorders
  
• A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00253110 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• Treatment of Behavioral Symptoms in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00009217 - Completed
  Alzheimer Disease
  
• A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-Manic Effectiveness of Risperidone Compared With Haloperidol
  ClinicalTrials.gov Identifier: NCT00253162 - Completed
  Manic Disorder; Bipolar Disorders
  
• Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates
  ClinicalTrials.gov Identifier: NCT00203775 - Terminated
  Psychosis; Aggression
  
• Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00169091 - Terminated
  Schizophrenia
  
• Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
  ClinicalTrials.gov Identifier: NCT00000274 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders